ConductScience.org, home

Paper39201617

Nanoparticles-Delivered Circular RNA Strategy as a Novel Antitumor Approach.

Racca L and 4 others. Int J Mol Sci, 2024. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Nanoparticles-Delivered Circular RNA Strategy as a Novel Antitumor Approach. Papers, record 39201617. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201617

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanoparticles-Delivered Circular RNA Strategy as a Novel Antitumor Approach.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
1.97, provisional
iCite
Revised in PubMed
2024-09-03
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RNA, CircularMajor topic
NeoplasmsMajor topic
NanoparticlesMajor topic
Humans
Animals
Genetic Therapy
Antineoplastic Agents

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ROL 76069-2021Fondazione CRTPubMed

Source PubMed

Download CSV of grants

References136

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130717751Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway.Mol Cancer2019https://conductscience.org/library/papers/30717751PubMed
230537986A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1.Genome Biol2018https://conductscience.org/library/papers/30537986PubMed
330794990Epidermal growth factor-nanoparticle conjugates change the activity from anti-apoptotic to pro-apoptotic at membrane rafts.Acta Biomater2019https://conductscience.org/library/papers/30794990PubMed
431185953Silencing of ANKRD12 circRNA induces molecular and functional changes associated with invasive phenotypes.BMC Cancer2019https://conductscience.org/library/papers/31185953PubMed
538282696Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer.Noncoding RNA Res2024https://conductscience.org/library/papers/38282696PubMed
636982236Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application.Int J Mol Sci2023https://conductscience.org/library/papers/36982236PubMed
729456858Enhanced biostability and cellular uptake of zinc oxide nanocrystals shielded with a phospholipid bilayer.J Mater Chem B2017https://conductscience.org/library/papers/29456858PubMed
833277608Engineering precision nanoparticles for drug delivery.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33277608PubMed
937056563Nanoparticle formulations for therapeutic delivery, pathogen imaging and theranostic applications in bacterial infections.Theranostics2023https://conductscience.org/library/papers/37056563PubMed
1036797769Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-𝜅B-IL-6 axis of tumor-associated macrophages.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/36797769PubMed
1125664725Exon-intron circular RNAs regulate transcription in the nucleus.Nat Struct Mol Biol2015https://conductscience.org/library/papers/25664725PubMed
1234684252Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis.Pathogens2021https://conductscience.org/library/papers/34684252PubMed
1331901148Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.Mol Oncol2020https://conductscience.org/library/papers/31901148PubMed
1434927541
Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.
Bioengineered2021https://conductscience.org/library/papers/34927541PubMed
1529581865Luminal breast cancer-specific circular RNAs uncovered by a novel tool for data analysis.Oncotarget2018https://conductscience.org/library/papers/29581865PubMed
1625242144circRNA biogenesis competes with pre-mRNA splicing.Mol Cell2014https://conductscience.org/library/papers/25242144PubMed
1737020690Nanoparticles Mediated circROBO1 Silencing to Inhibit Hepatocellular Carcinoma Progression by Modulating miR-130a-5p/CCNT2 Axis.Int J Nanomedicine2023https://conductscience.org/library/papers/37020690PubMed
1827886165Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity.Cell Death Differ2017https://conductscience.org/library/papers/27886165PubMed
1937296107CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets.Cell Death Dis2023https://conductscience.org/library/papers/37296107PubMed
2033896342A promising dual-drug targeted delivery system in cancer therapy: nanocomplexes of folate-apoferritin-conjugated cationic solid lipid nanoparticles.Pharm Dev Technol2021https://conductscience.org/library/papers/33896342PubMed

See all 136 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42780376Emerging strategies and innovations in circular RNA synthesis.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42780376PubMed
41799520Circular RNAs: Key Regulators of Tumor Metabolic Reprogramming and Clinical Translation.Oncol Res2026https://conductscience.org/library/papers/41799520PubMed
41632314Circular RNAs: key regulators in cancer stem cell dynamics.Mol Genet Genomics2026https://conductscience.org/library/papers/41632314PubMed
41353994Circular RNAs in cancer immunology: Immune escape, therapeutic resistance, and nanomedicine synergies.Transl Oncol2026https://conductscience.org/library/papers/41353994PubMed
41299798Exploring the role of circular RNAs in endometrial cancer progression and chemoresistance: Implications for targeted therapies.Eur J Med Res2025https://conductscience.org/library/papers/41299798PubMed
41141671Advances in the research on circular RNA in pediatric pancreatic tumors.Transl Pediatr2025https://conductscience.org/library/papers/41141671PubMed
40945848Decoding the functional network of circular RNAs encoding proteins in hepatocellular carcinoma: from carcinogenesis to clinical transformation.J Adv Res2026https://conductscience.org/library/papers/40945848PubMed
39901896Circular RNAs in cancer.MedComm (2020)2025https://conductscience.org/library/papers/39901896PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39201617

GET https://conductscience.org/api/papers/v1/39201617/references?page=2